Etodesnitazepyne

Etodesnitazepyne

Molecular structure via molpic based on CDK

Physical properties []
Molecular mass	349.5 g/mol ^[1]
Predicted LogP	4.2 ^[1]

Structural Identifiers []
Molecular formula	C₂₂H₂₇N₃O ^[1]
IUPAC name	2-[(4-ethoxyphenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)benzimidazole ^[1]
SMILES	CCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN4CCCC4 ^[1]
InChI	InChI=1S/C22H27N3O/c1-2-26-19-11-9-18(10-12-19)17-22-23-20-7-3-4-8-21(20)25(22)16-15-24-13-5-6-14-24/h3-4,7-12H,2,5-6,13-17H2,1H3 ^[1]
InChIKey	TUWFBDYIBNYRKD-UHFFFAOYSA-N ^[1]

Etodesnitazepyne (also known as Etodesnitazene pyrrolidine analogue, 2-(4-Ethoxy-benzyl)-1-(2-pyrrolidin-1-yl-ethyl)-1h-benzoimidazole, 1H-benzimidazole, 2-((4-ethoxyphenyl)methyl)-1-(2-(1-pyrrolidinyl)ethyl)- or N-Pyrrolidino Etodesnitazene) is a opioid substance of the nitazepyne class.

Chemistry

Stereochemistry []

Etodesnitazepyne is a achiral mixture.

Subjective effects []

class / Opioid

Physical effects
Constipation Cough suppression Difficulty urinating Itchiness Nausea Pain relief Pupil constriction Respiratory depression Sedation Stomach cramp

Cognitive effects
Anxiety suppression Cognitive euphoria Compulsive redosing Increased music appreciation Thought deceleration

Visual effects
Double vision

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 162623599, Etodesnitazepyne. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/162623599
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Etodesnitazepyne. UNII: 9XR67A2LKR. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9XR67A2LKR

AnodyneWiki